H. Raafat

963 total citations
50 papers, 615 citations indexed

About

H. Raafat is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, H. Raafat has authored 50 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 17 papers in Epidemiology and 15 papers in Rheumatology. Recurrent topics in H. Raafat's work include Pneumonia and Respiratory Infections (17 papers), Respiratory and Cough-Related Research (14 papers) and Systemic Lupus Erythematosus Research (10 papers). H. Raafat is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Respiratory and Cough-Related Research (14 papers) and Systemic Lupus Erythematosus Research (10 papers). H. Raafat collaborates with scholars based in Egypt, United States and Netherlands. H. Raafat's co-authors include A. Pines, Tamer A. Gheita, M. M. Nasrallah, Brenda Mullinger, Mizanur Rahman, Amos Pines, J R Whittington, Anthony Lynn, Nouran Abaza and Dina H. El-Hammady and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of Antimicrobial Chemotherapy.

In The Last Decade

H. Raafat

48 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Raafat Egypt 14 260 172 113 85 68 50 615
Prayong Vachvanichsanong Thailand 17 139 0.5× 161 0.9× 131 1.2× 46 0.5× 29 0.4× 58 838
Duncan E. Govan United States 15 234 0.9× 406 2.4× 284 2.5× 64 0.8× 25 0.4× 30 1.1k
G S Basran United Kingdom 17 252 1.0× 89 0.5× 48 0.4× 74 0.9× 11 0.2× 29 649
George A. Richard United States 13 73 0.3× 117 0.7× 82 0.7× 47 0.6× 20 0.3× 34 425
P Géhanno France 13 139 0.5× 229 1.3× 18 0.2× 123 1.4× 46 0.7× 70 581
Hani P. Grewal United States 25 124 0.5× 425 2.5× 17 0.2× 57 0.7× 22 0.3× 80 2.2k
R M Chichmanian France 12 49 0.2× 88 0.5× 26 0.2× 86 1.0× 9 0.1× 53 498
Kenji Umeki Japan 12 161 0.6× 233 1.4× 18 0.2× 20 0.2× 32 0.5× 42 542
Erica Anderson United States 7 75 0.3× 147 0.9× 31 0.3× 22 0.3× 13 0.2× 21 656
M Alfaham United Kingdom 13 219 0.8× 80 0.5× 67 0.6× 65 0.8× 10 0.1× 25 638

Countries citing papers authored by H. Raafat

Since Specialization
Citations

This map shows the geographic impact of H. Raafat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Raafat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Raafat more than expected).

Fields of papers citing papers by H. Raafat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Raafat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Raafat. The network helps show where H. Raafat may publish in the future.

Co-authorship network of co-authors of H. Raafat

This figure shows the co-authorship network connecting the top 25 collaborators of H. Raafat. A scholar is included among the top collaborators of H. Raafat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Raafat. H. Raafat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raafat, H., et al.. (2021). Predictors of airway and parenchymal lung abnormalities in patients with rheumatoid arthritis. SHILAP Revista de lepidopterología. 43(2). 125–130. 1 indexed citations
2.
Tharwat, Samar, Rasha M. Fawzy, Abdelhfeez Moshrif, et al.. (2020). Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient. Rheumatology International. 41(2). 345–353. 38 indexed citations
3.
4.
Raafat, H., et al.. (2015). Intima-media thickness in secondary anti-phospholipid syndrome patients: Impact of disease activity. The Egyptian Rheumatologist. 37(2). 55–60. 4 indexed citations
5.
Raafat, H., et al.. (2015). Down-regulation of expression of retinoid acid-related orphan receptor C (RORC) in systemic lupus erythematosus. Journal of Receptors and Signal Transduction. 36(2). 207–212. 5 indexed citations
6.
Gheita, Tamer A., et al.. (2013). Serum level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity. Modern Rheumatology. 23(3). 542–546. 17 indexed citations
7.
Gheita, Tamer A., et al.. (2012). Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Zeitschrift für Rheumatologie. 72(2). 172–177. 46 indexed citations
8.
Gheita, Tamer A., et al.. (2012). Serum level of APRIL/BLyS in Behçet’s disease patients: clinical significance in uveitis and disease activity. Modern Rheumatology. 23(3). 542–546. 20 indexed citations
9.
Emad, Yasser, et al.. (2008). Enhanced MRI in early undifferentiated oligoarthritis of the knee joints: Improvements already visible after 2 months of DMARDs treatment. Clinical Rheumatology. 27(9). 1177–1182. 6 indexed citations
10.
Pines, A., et al.. (1981). Cefuroxime and Ampicillin Compared in a Double-Blind Study in the Treatment of Lower Respiratory Tract Infections. Chemotherapy. 27(6). 459–465. 13 indexed citations
11.
Pines, A., et al.. (1980). Experience with Cefuroxime in 190 Patients with Severe Respiratory Infections. Chemotherapy. 26(3). 212–217. 3 indexed citations
12.
Pines, A., et al.. (1977). Pivmecillinam and amoxycillin as combined treatment in purulent exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 3(suppl B). 141–148. 8 indexed citations
13.
Pines, A., et al.. (1974). The management of purulent exacerbations of chronic bronchitis. A comparison of minocycline and tetracycline hydrochloride.. PubMed. 213(1277). 727–9. 7 indexed citations
14.
Pines, A., et al.. (1972). The management of purulent exacerbations of chronic bronchitis. A comparison of co-trimoxazole and tetracycline.. PubMed. 208(244). 265–7. 8 indexed citations
15.
Pines, A., et al.. (1972). A Double‐blind Comparison of Slow‐release Tetracycline and Tetracycline Hydrochloride in Purulent Exacerbations of Chronic Bronchitis. International Journal of Clinical Practice. 26(10). 475–476. 6 indexed citations
16.
Pines, A., et al.. (1971). Penicillin, ampicillin and cephaloridine in severe exacerbations of purulent chronic bronchitis in elderly patients. British Journal of Diseases of the Chest. 65(2). 91–97. 10 indexed citations
17.
Pines, A., et al.. (1970). Treatment of Severe Pseudomonas Infections of the Bronchi. BMJ. 1(5697). 663–665. 39 indexed citations
18.
Pines, A. & H. Raafat. (1968). Chloramphenicol and tetracyclines.. BMJ. 3(5617). 557.2–557. 1 indexed citations
19.
Pines, A., et al.. (1968). Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.. BMJ. 2(5607). 735–738. 62 indexed citations
20.
Pines, A., et al.. (1967). Gentamicin and colistin in chronic purulent bronchial infections.. BMJ. 2(5551). 543–545. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prayong Vachvanichsanong Breakdown of academic impact, for papers by Duncan E. Govan Breakdown of academic impact, for papers by G S Basran Breakdown of academic impact, for papers by George A. Richard Breakdown of academic impact, for papers by P Géhanno Breakdown of academic impact, for papers by Hani P. Grewal Breakdown of academic impact, for papers by R M Chichmanian Breakdown of academic impact, for papers by Kenji Umeki Breakdown of academic impact, for papers by Erica Anderson Breakdown of academic impact, for papers by M Alfaham
Rankless by CCL
2026